Loqtorzi

Active Ingredient(s): Toripalimab-tpzi
FDA Approved: * October 27, 2023
Pharm Company: * COHERUS BIOSCIENCES INC
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Loqtorzi 240 mg/6ml Intravenous Injection
NDC: 70114-340
Labeler:
Coherus Biosciences, Inc.